Condition: Aphasia · Stroke · Sponsor: Johns Hopkins University
In this project, the investigators will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as measured by naming untrained pictures and describing pictures, in individuals with aphasia in the acute and subacute post stroke period (i.e., within three months post stroke).
This description comes directly from the study's public registry record.
Argye Hillis-Trupe, MD · (410) 614-2381 · argye@jhmi.edu
Melissa D Stockbridge, PhD · md.stockbridge@jhmi.edu
Always discuss trial participation with your own doctor first.
| Johns Hopkins School of Medicine | Baltimore, Maryland, United States | Recruiting |
| Medical University of South Carolina | Charleston, South Carolina, United States | Recruiting |
| University of South Carolina | Columbia, South Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03843463